Versatile Manufacturing Capacity Laboratorios Alcala Farma's ability to produce a wide range of pharmaceutical forms and formats, including solid, semi-solid, liquids, sterile products, and innovative soft gelatin capsules and sticks packs, presents extensive manufacturing opportunities for companies seeking comprehensive CDMO services.

European Market Expertise With specialized R&D capabilities and full registration dossier development aligned with European and non-European regulatory requirements, Alcala Farma is well-positioned to support foreign clients aiming to penetrate European markets with novel or reformulated products.

Strategic Acquisition Advantage As part of the Synerlab Group following its acquisition in 2015, Alcala Farma benefits from expanded European reach and financial backing, enabling it to take on larger projects and increase market share, offering growth opportunities for new partners.

Proprietary and Innovative Portfolio The company's focus on developing proprietary OTC and Food Supplement products, coupled with ongoing innovation, makes it an attractive partner for brands looking to expand or strengthen their private label or new product lines in the health and wellness sectors.

Technological Capabilities Employing a range of modern technologies and analytics tools, Alcala Farma maintains efficient production and quality control processes, providing assurance of high product standards and consistent supply for potential collaborators.